Regeneron’s COVID-19 treatment gets emergency approval from FDA

Regeneron’s COVID-19 treatment gets emergency approval from FDA


The U.S. Food and Drug Administration has given the green light for emergency use of Regeneron’s COVID-19 antibody drug — the same treatment given to President Trump.

The treatment is aimed at those with mild cases of COVID-19, and not for those hospitalized as a result of the virus, the FDA said.

The treatment works by mimicking the body’s own immune system to prevent the infected from become severely ill.

Trending: What Was In Those Bush Sr. Funeral Envelopes and Why Did Mike Pence Get One?

Regeneron’s drug is a combination of two monoclonal antibodies. A similar drug developed by Eli Lilly & Co. gained FDA emergency clearance earlier this month.

However the Regeneron treatment may not be immediately widely available: the company has said it will have just 80,000 doses by the end of November.

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!
Send this to a friend